Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation-Reference-Cited by-同舟云学术

Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation

Published:2019-09-06 Issue:11 Volume:18 Page:1017-1030
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

El Helou Guy¹^ORCID,Razonable Raymund R¹

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, and William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic College of Medicine and Science, Rochester, MN, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1662787

Reference169 articles.

1. Human Cytomegalovirus Latency: Approaching the Gordian Knot

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

3. New Developments in the Management of Cytomegalovirus Infection After Transplantation

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Monitoring of the Effects of Anti-Adenoviral Treatment Regimens in a Permissive In Vivo Model;Viruses;2024-07-26

2. NPP-669, a prodrug of cidofovir, is highly efficacious against human adenovirus infection in the permissive Syrian hamster model;Antimicrobial Agents and Chemotherapy;2024-07-09

3. Varicella‐zoster virus‐related neurological complications: From infection to immunomodulatory therapies;Reviews in Medical Virology;2024-06-11

5. Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamsters;Antiviral Research;2024-02